Neurocrine Biosciences to acquire Soleno Therapeutics in $2.9B deal

Neurocrine Biosciences (NASDAQ:NBIX) has agreed to acquire Soleno Therapeutics (NASDAQ:SLNO) in an all-cash transaction valued at approximately $2.9...